# Effect of Injectable Anticoagulants on Research for a Circulating Lupus-type Anticoagulant

> **NCT05416190** · NA · COMPLETED · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 188 (actual)

## Conditions studied

- Antiphospholipid Syndrome
- Anticoagulant Drugs

## Interventions

- **DIAGNOSTIC_TEST:** Lupus anticoagulant testing

## Key facts

- **NCT ID:** NCT05416190
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-02
- **Primary completion:** 2024-05-21
- **Final completion:** 2024-05-21
- **Target enrollment:** 188 (ACTUAL)
- **Last updated:** 2024-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05416190

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05416190, "Effect of Injectable Anticoagulants on Research for a Circulating Lupus-type Anticoagulant". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05416190. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*